HomeCompareGILPX vs JNJ

GILPX vs JNJ: Dividend Comparison 2026

GILPX yields 4.27% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GILPX wins by $6.4K in total portfolio value
10 years
GILPX
GILPX
● Live price
4.27%
Share price
$24.52
Annual div
$1.05
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$561.06
Full GILPX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GILPX vs JNJ

📍 GILPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGILPXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GILPX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GILPX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GILPX
Annual income on $10K today (after 15% tax)
$362.72/yr
After 10yr DRIP, annual income (after tax)
$476.90/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $226.71/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GILPX + JNJ for your $10,000?

GILPX: 50%JNJ: 50%
100% JNJ50/50100% GILPX
Portfolio after 10yr
$23.2K
Annual income
$694.42/yr
Blended yield
2.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GILPX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GILPX buys
0
JNJ buys
0
No recent congressional trades found for GILPX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGILPXJNJ
Forward yield4.27%3.36%
Annual dividend / share$1.05$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$26.4K$20.0K
Annual income after 10y$561.06$827.78
Total dividends collected$5.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GILPX vs JNJ ($10,000, DRIP)

YearGILPX PortfolioGILPX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,127$426.73$10,676$355.77+$451.00GILPX
2$12,349$443.74$11,407$389.39+$942.00GILPX
3$13,674$460.28$12,198$426.53+$1.5KGILPX
4$15,108$476.32$13,056$467.62+$2.1KGILPX
5$16,657$491.82$13,987$513.12+$2.7KGILPX
6$18,330$506.79$14,998$563.56+$3.3KGILPX
7$20,134$521.20$16,098$619.52+$4.0KGILPX
8$22,078$535.05$17,295$681.69+$4.8KGILPX
9$24,172$548.33$18,599$750.82+$5.6KGILPX
10$26,425$561.06$20,022$827.78+$6.4KGILPX

GILPX vs JNJ: Complete Analysis 2026

GILPXStock

The investment seeks to provide a high level of income consistent with preservation of capital. The advisor intends to pursue its investment objective by investing at least 80% of its assets (net assets, plus the amount of any borrowings for investment purposes) in a diversified portfolio of debt securities, financial instruments that should perform similarly to debt securities and investment vehicles that provide exposure to debt securities, and debt-like securities, including individual securities, investment vehicles and derivatives giving exposure (i.e. similar economic characteristics) to fixed-income markets.

Full GILPX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GILPX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GILPX vs SCHDGILPX vs JEPIGILPX vs OGILPX vs KOGILPX vs MAINGILPX vs ABBVGILPX vs MRKGILPX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.